4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-110797
Director sold 30,974 shares at an average $35.50 ($1,099,697)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-09-27 | Sale 10b5-1 | −32 | $35.00 | $1,120 | 189,647 | I |
| Kersten Dirk Director | 2024-09-30 | Sale 10b5-1 | −29,007 | $35.47 | $1,028,878 | 160,640 | I |
| Kersten Dirk Director | 2024-09-30 | Sale 10b5-1 | −1,935 | $36.02 | $69,699 | 158,705 | I |
| Open-market sales · 30,974 sh · avg $35.50 · $1,099,697 | |||||||
Loading xslF345X05/ownership.xml…